Integrated BioPharma (OTCMKTS:INBP – Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.02) earnings per share (EPS) for the quarter, Zacks reports. Integrated BioPharma had a negative return on equity of 14.78% and a negative net margin of 6.48%.
Integrated BioPharma Price Performance
Shares of INBP remained flat at $0.17 on Friday. The company has a 50 day moving average of $0.18 and a 200-day moving average of $0.22. Integrated BioPharma has a one year low of $0.14 and a one year high of $0.42. The company has a market capitalization of $5.12 million, a price-to-earnings ratio of -1.65 and a beta of 0.49.
Integrated BioPharma Company Profile
Integrated BioPharma, Inc. is a healthcare and consumer-products company that manufactures, distributes and markets vitamins, nutritional supplements, herbal products and specialty pharmaceutical products. Its activities include producing health and wellness products for its own brands as well as providing contract manufacturing services for other businesses. The company’s product offerings have included dietary supplements, botanical and herbal formulations, vitamins, minerals and other nutrition-related products.
Featured Stories
- Five stocks we like better than Integrated BioPharma
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
